Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19

Author:

Owens Cameron D12ORCID,Bonin Pinto Camila12,Detwiler Sam1,Olay Lauren1,Pinaffi-Langley Ana Clara da C1,Mukli Peter123,Peterfi Anna123,Szarvas Zsofia123,James Judith A1456,Galvan Veronica178,Tarantini Stefano123910,Csiszar Anna123,Ungvari Zoltan12310,Kirkpatrick Angelia C811,Prodan Calin I812,Yabluchanskiy Andriy12310ORCID

Affiliation:

1. Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73117 , USA

2. Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 , USA

3. International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Departments of Public Health, Translational Medicine and Physiology, Semmelweis University , Budapest, 1089 , Hungary

4. Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation , Oklahoma City, OK 73104 , USA

5. Department of Internal Medicine, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 , USA

6. Department of Pathology, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 , USA

7. Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 , USA

8. Veterans Affairs Medical Center , Oklahoma City, OK 73104 , USA

9. The Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 , USA

10. Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 , USA

11. Cardiovascular Section, Department of Medicine, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73117 , USA

12. Department of Neurology, University of Oklahoma Health Sciences Center , Oklahoma City, OK 73104 , USA

Abstract

Abstract Components that comprise our brain parenchymal and cerebrovascular structures provide a homeostatic environment for proper neuronal function to ensure normal cognition. Cerebral insults (e.g. ischaemia, microbleeds and infection) alter cellular structures and physiologic processes within the neurovascular unit and contribute to cognitive dysfunction. COVID-19 has posed significant complications during acute and convalescent stages in multiple organ systems, including the brain. Cognitive impairment is a prevalent complication in COVID-19 patients, irrespective of severity of acute SARS-CoV-2 infection. Moreover, overwhelming evidence from in vitro, preclinical and clinical studies has reported SARS-CoV-2-induced pathologies in components of the neurovascular unit that are associated with cognitive impairment. Neurovascular unit disruption alters the neurovascular coupling response, a critical mechanism that regulates cerebromicrovascular blood flow to meet the energetic demands of locally active neurons. Normal cognitive processing is achieved through the neurovascular coupling response and involves the coordinated action of brain parenchymal cells (i.e. neurons and glia) and cerebrovascular cell types (i.e. endothelia, smooth muscle cells and pericytes). However, current work on COVID-19-induced cognitive impairment has yet to investigate disruption of neurovascular coupling as a causal factor. Hence, in this review, we aim to describe SARS-CoV-2's effects on the neurovascular unit and how they can impact neurovascular coupling and contribute to cognitive decline in acute and convalescent stages of the disease. Additionally, we explore potential therapeutic interventions to mitigate COVID-19-induced cognitive impairment. Given the great impact of cognitive impairment associated with COVID-19 on both individuals and public health, the necessity for a coordinated effort from fundamental scientific research to clinical application becomes imperative. This integrated endeavour is crucial for mitigating the cognitive deficits induced by COVID-19 and its subsequent burden in this especially vulnerable population.

Funder

National Institute on Aging

American Heart Association

Oklahoma Shared Clinical and Translational Resources

National Cancer Institute

National Institute of Neurological Disorders and Stroke

Department of Veterans Affairs Merit

Department of Veterans Affairs Clinical Science Research & Development Service

Publisher

Oxford University Press (OUP)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3